| a role of LRIG1 in tumor suppression in the uterine cervix | uterine, |
| Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. | breast, |
| LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer | colorectal, |
| Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma | glioma, |
| Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR | lung, |
| LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer | prostate, |
| Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer | prostate, |
| The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastoma | glioblastoma, |
| Study demonstrates that Lrig1 null mice develop duodenal adenomas, providing in vivo evidence that the ErbB negative regulator Lrig1 functions as a tumor suppressor. | None |
| A review summarizes the data that LRIG1 is a ERBB negative regulator and tumour suppressor. | None |